Posted On: 11/16/2012 2:18:34 PM
Post# of 2145
Listed below are products currently being commercialized, and a high level timeline\ estimates of future product launches.
Commercial Product List | ||||
Short term (fiscal 2013) expectations | ||||
Name | Status | Owner | ||
1 | Phentermine 37.5mg | Launched | Elite | |
2 | Hydromorphone 8mg | Launched | Elite | |
3 | Lodrane D | Launched | ECR | |
4 | Methadone 10mg | Launched | PharmaNet | |
5 | Phendimetrazine 10mg | Launched | Mikah | |
6 | Naltrexone 50mg | Pending Approval | Elite | |
7 | Phentermine 15mg | Approved - Awaiting API | Elite | |
8 | Phentermine 30mg | Approved - Awaiting API | Elite | |
Fiscal 2014 expectations | ||||
1 | Undisclosed Generic | Pending Approval | Elite | |
2 | Undisclosed ANDA | Pending Approval | Epic | |
3 | Lodrane CR 12 & 24 | ECR | ||
4 | ANDA\NDA 505b2 product | Elite |
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)